Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
ACR Appropriateness Criteria® Suspected Abdominal Neoplasm-Child.
Journal: Journal of the American College of Radiology : JACR
Published: February 05, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data.
Journal: Journal of the National Cancer Institute
Published: December 08, 2025
Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa Ependymoma.
Journal: Neuro-oncology
Published: October 26, 2025
Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.
Journal: Neuro-oncology
Published: October 26, 2025
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study.
Journal: Pediatric blood & cancer
Published: October 03, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 29, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 23, 2025
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.
Journal: Pediatric blood & cancer
Published: April 11, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 10, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Journal: Pediatric blood & cancer
Published: February 26, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.
Journal: Pediatric blood & cancer
Published: November 21, 2024
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.
Journal: Pediatric blood & cancer
Published: November 14, 2024
Last Updated: 09/26/2026